Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
05/1998
05/20/1998EP0383799B1 Adheson variants
05/20/1998DE19647282A1 Composition for preparing tablets or suckable sweets
05/20/1998CN1182372A Pharmaceuticals and assays using enzyme subunits
05/20/1998CN1182371A Formulations for lipophilic compounds
05/20/1998CN1182369A Pharmaceutical compositions for controlled release of soluble receptors
05/20/1998CN1182365A Pharmaceutical compostion for transdermic delivery
05/20/1998CN1182358A Triacetin as transdermal penetration enhancer
05/20/1998CN1181974A Stabilized albumin-free recombinant factor VIII preparation having low sugar content
05/20/1998CN1181931A Composition for transdermal delivery system containing nonsteroidal anti-inflammatory drug as active ingredient
05/20/1998CN1181930A Locally delayed-release free-radical forming agent
05/19/1998US5753646 Substituted dihydrodibenzo/b,f/azepines, method of their preparation, their use in the treatment of some central nervous system disorders, and pharmaceutical compositions containing them
05/19/1998US5753636 Containing oxytetracycline complexed with magnesium, polyvinylpyrrolidone, a basic amino acid, and an additive in a solvent; free of chloride ions; solubility, stability
05/19/1998US5753631 Intercellular adhesion mediators
05/19/1998US5753618 Somatostatin analogue composition and use in treating breast cancer
05/19/1998US5753613 Drug delivery using a complexes containing an ammonium quaternary compound and lipid; transfection
05/19/1998US5753611 Pharmaceutical composition having site-specific delivery
05/19/1998US5753520 Protein labelling
05/19/1998US5753503 Capable of selectively binding to gp41 of envelope protein of human immunodeficiency virus type 1
05/19/1998US5753428 Synthetic composition for storage of platelets comprising glycerol
05/19/1998US5753266 Safflower seed powder compositions for the treatment of rheumatoid based arthritic diseases
05/19/1998US5753264 Method of making positively charged microcapsules of emulsions of oils and its uses
05/19/1998US5753259 Method of preparing controlled-release preparations for biologically active materials and resulting compositions
05/19/1998US5753256 Plaster for the treatment of nail mycoses
05/19/1998US5753244 Adding an encapsulated color changing indicator to a topical skin formulation
05/19/1998US5753240 Perfluorinated alkyl-n-alkyloxycarbonyl-alkylcarbamates used as thickening agents in drugs and cosmetics
05/19/1998US5753234 Single-shot vaccine formulation
05/19/1998US5753219 Trehalose, controlled release
05/19/1998CA2093666C Orally administered solvent-free pharmaceutical preparation with delayed active-substance release, and a method of preparing the preparation
05/14/1998WO1998020135A2 Protease-activatable pseudomonas exotoxin a-like proproteins
05/14/1998WO1998020094A2 Compositions for disinfection of skin and mucous membrane
05/14/1998WO1998020044A1 Acylated cyclodextrin derivatives
05/14/1998WO1998020037A1 Method for treating certain pediatric acute leukemias
05/14/1998WO1998019783A2 Twin surfactants
05/14/1998WO1998019710A2 Delivery of nucleic acid material to target cells in biological systems
05/14/1998WO1998019709A2 Cationic reagents for transfection
05/14/1998WO1998019708A2 Method for enhancing the solubility of substantially water-insoluble compounds
05/14/1998WO1998019707A1 Polyhydroxy monocarboxylic and dicarboxylic acids and their lactones in ophthalmic compositions
05/14/1998WO1998019705A1 Branched peptide linkers
05/14/1998WO1998019697A2 Novel pharmaceutical compositions
05/14/1998WO1998019694A1 Therapeutic uses of bpi protein products in cystic fibrosis patients
05/14/1998WO1998019663A1 Compositions for topical use containing polysaccharide sulphates
05/14/1998WO1998019565A1 Edible preservative and acidulant composition
05/14/1998WO1998005684A3 Mhc binding peptide oligomers and methods of use
05/14/1998WO1998001162A3 Gene delivery system
05/14/1998WO1998000172A3 Compositions and methods for altering the biodistribution of biological agents
05/14/1998WO1997044064A3 Oligonucleotides which specifically bind retroviral nucleocapsid proteins
05/14/1998DE19701912C1 Implant for controlled drug release
05/14/1998DE19646587A1 Neue Fettalkoholsulfate und Alkylethersulfate mit Trialkylammonium-Gegenionen sowie ihre Herstellung und Verwendung New fatty alcohol sulfates and alkyl ether sulfates with trialkylammonium counter ions as well as their preparation and use
05/14/1998DE19646392A1 Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht Preparation with a pressure-sensitive adhesive for use in the oral cavity to the mucosa, pharmaceuticals or cosmetics for metering layer containing
05/14/1998DE19646050A1 Transdermal therapeutic system e.g. containing testosterone, melatonin
05/14/1998CA2271291A1 Protease-activatable pseudomonas exotoxin a-like proproteins
05/14/1998CA2271006A1 Delivery of nucleic acid material to target cells in biological systems
05/14/1998CA2270927A1 Novel pharmaceutical compositions
05/14/1998CA2270432A1 Edible preservative and acidulant composition
05/14/1998CA2270290A1 Therapeutic uses of bpi protein products in cystic fibrosis patients
05/14/1998CA2264610A1 Branched peptide linkers
05/14/1998CA2247410A1 Method for enhancing the solubility of substantially water-insoluble compounds
05/14/1998CA2221010A1 Matrix material comprising several bio-active materials
05/13/1998EP0841067A1 Freeze-dried preparation containing monoclonal antibody
05/13/1998EP0841066A1 Stable freeze-dried composition containing tpo
05/13/1998EP0841010A1 Stable compositions dispersible in cold water
05/13/1998EP0840797A1 Methods and means for targeted gene delivery
05/13/1998EP0840796A2 Mucosal delivery of polynucleotides
05/13/1998EP0840744A1 Phosphonic acid-based cationic lipids
05/13/1998EP0840623A1 A method for gene therapy using nucleic acid loaded polymeric microparticles
05/13/1998EP0840621A1 Hormone patch
05/13/1998EP0840619A1 Prevention and treatment of sepsis
05/13/1998EP0840611A1 Oral acyclovir delivery
05/13/1998EP0840600A1 Transdermal patch containing aspirin
05/13/1998EP0840599A1 Pharmaceutical compositions of conjugated estrogens and methods for their use
05/13/1998EP0840570A2 Apparatus and method for making gas-filled vesicles of optimal size
05/13/1998EP0840555A1 Stabilisation of flavourants
05/13/1998EP0783535B1 Process for preparing aqueous solutions of poly(n-vinyl-epsilon-caprolactam) and their use
05/13/1998EP0591492B1 A pharmaceutical composition containing a defined lipid system
05/13/1998EP0375736B1 Nucleic acid fragments encoding mannose binding fragments of human mannose binding protein
05/13/1998CN1181783A Medical composition
05/13/1998CN1181760A Lipophilic peptide hormone derivatives
05/13/1998CN1181705A Gel form of a vaccine
05/13/1998CN1181703A Controlled release of miotic and mydriatic drugs in the anterior chamber
05/13/1998CN1181698A Method for topical treatment of scar tissue and related tissue reaction to trauma
05/13/1998CN1181238A preparations
05/13/1998CN1038304C Method for prepn. of growth inhibiting compsn.
05/12/1998US5750725 Hemoglobin crosslinkers
05/12/1998US5750678 Water-soluble dextran fatty acid esters and their use as solubilizers
05/12/1998US5750579 Solution of disinfectant, alcohol, thickener
05/12/1998US5750563 Preparation for epidermis
05/12/1998US5750561 Compositions containing taxane derivatives
05/12/1998US5750512 For treatment of parkinson's and alzheimer's disease or mental depression
05/12/1998US5750373 Fusing gene coding a protein of interest to carboxy terminal domain of the gene coat protein of the filamentous phage m13, mutating
05/12/1998US5750148 Cellulosic enteric base
05/12/1998US5750147 Fungicides for oral administration
05/12/1998US5750146 Translucent collagen formulations with a cytotoxic drug
05/12/1998US5750142 Lyophilized; cryoprotectants; emulsifiers; oil in water emulsion
05/12/1998US5750140 Transdermal delivery of tiagabine
05/12/1998US5750137 Drug delivery, permeability, glycerides and lactates
05/12/1998US5750136 Mucosal surfaces; drug delivery; sustained release
05/12/1998US5750131 Ifosfamide lyophilizate preparations
05/12/1998US5750122 Compositions for treating hair or skin
05/12/1998US5750103 Method for transplanting cells into the brain and therapeutic uses therefor
05/12/1998US5750100 Drug delivery of an active peptide or protein by injection or implantation by incorporating in a matrix of a polyglycerol diester of a saturated fatty acid; nondenaturing; antiallergens
1 ... 1465 1466 1467 1468 1469 1470 1471 1472 1473 1474 1475 1476 1477 1478 1479 1480 1481 1482 1483 1484 1485 ... 1712